
Probiotics or so-called "friendly" bacteria can be used to protect hospital patients from developing pneumonia, a Swedish study has concluded.
According to boffins, probiotics can block the colonization by dangerous bugs of the airways of ventilated patients.
Advertisement
Pneumonia is a common complication in patients on breathing machines and occurs when harmful bacteria from the mouth, throat or breathing tube are inhaled into the lungs.
The journal Critical Care reported that the probiotic solution performed just as well as normal antiseptics, which are used to keep pneumonia-causing bacteria at bay.
Since it is more natural it could pose fewer side effects, the experts said.
Patients swabbed with probiotic bacteria called Lactobacillus plantarum 299 escaped infection as well as those cleaned up using the antiseptic chlorhexidine, they reported.
Both approaches worked equally well in preventing pneumonia among 50 critically ill patients using ventilators, Bengt Klarin of University Hospital in Lund, Sweden, and colleagues found.
In addition, a probiotic that adheres to mouth lining will be able to work around the clock, unlike antiseptics, which wear off after a few hours, say the authors.
"This is a plausible idea. But we need much larger trials that focus on clinical outcomes to prove it is an effective and affordable treatment," BBC quoted Bob Marsterton, chair of the British Society for Antimicrobial Chemotherapy's working party on hospital acquired pneumonia, as saying.
Source: ANI
SK
Advertisement
Since it is more natural it could pose fewer side effects, the experts said.
Patients swabbed with probiotic bacteria called Lactobacillus plantarum 299 escaped infection as well as those cleaned up using the antiseptic chlorhexidine, they reported.
Both approaches worked equally well in preventing pneumonia among 50 critically ill patients using ventilators, Bengt Klarin of University Hospital in Lund, Sweden, and colleagues found.
In addition, a probiotic that adheres to mouth lining will be able to work around the clock, unlike antiseptics, which wear off after a few hours, say the authors.
"This is a plausible idea. But we need much larger trials that focus on clinical outcomes to prove it is an effective and affordable treatment," BBC quoted Bob Marsterton, chair of the British Society for Antimicrobial Chemotherapy's working party on hospital acquired pneumonia, as saying.
Source: ANI
SK
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News

The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.

A combinatorial therapy provided promising beneficial results among people with ischemic stroke.

In Parkinson's disease patients voice disorders are quite common. A new combination therapy had greater effects on the voice.

New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.

A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.